Literature DB >> 19049903

DNA and chromosomal damage in response to intermittent extremely low-frequency magnetic fields.

Susanne Burdak-Rothkamm1, Kai Rothkamm, Melvyn Folkard, Gaurang Patel, Pat Hone, David Lloyd, Liz Ainsbury, Kevin M Prise.   

Abstract

Considerable controversy still exists as to whether electric and magnetic fields (MF) at extremely low frequencies are genotoxic to humans. The aim of this study was to test the ability of alternating magnetic fields to induce DNA and chromosomal damage in primary human fibroblasts. Single- and double-strand breaks were quantified using the alkaline comet assay and the gammaH2AX-foci assay, respectively. Chromosomal damage was assayed for unstable aberrations, sister chromatid exchange and micronuclei. Cells were exposed to switching fields - 5min on, 10min off - for 15h over the range 50-1000microT. Exposure to ionizing radiation was used as a positive-effect calibration. In this study two separate MF exposure systems were used. One was based on a custom-built solenoid coil system and the other on a commercial system almost identical to that used in previous studies by the EU REFLEX programme. With neither system could DNA damage or chromosomal damage be detected as a result of exposure of fibroblasts to switching MF. The sensitive gammaH2AX assay could also not detect significant DNA damage in the MF-exposed fibroblasts, although the minimum threshold for this assay was equivalent to an X-ray dose of 0.025Gy. Therefore, with comparable MF parameters employed, this study could not confirm previous studies reporting significant effects for both the alkaline and neutral comet assays and chromosomal aberration induction.

Entities:  

Mesh:

Year:  2008        PMID: 19049903     DOI: 10.1016/j.mrgentox.2008.10.016

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  8 in total

1.  Hazard zoning around electric substations of petrochemical industries by stimulation of extremely low-frequency magnetic fields.

Authors:  Monireh Hosseini; Mohammad Reza Monazzam; Laleh Farhang Matin; Hossein Khosroabadi
Journal:  Environ Monit Assess       Date:  2015-04-16       Impact factor: 2.513

Review 2.  The Impact of the Low Frequency of the Electromagnetic Field on Human.

Authors:  Kawthar A Diab
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 3.  Electromagnetic fields act via activation of voltage-gated calcium channels to produce beneficial or adverse effects.

Authors:  Martin L Pall
Journal:  J Cell Mol Med       Date:  2013-06-26       Impact factor: 5.310

4.  Extremely Low-Frequency Electromagnetic Fields Affect the miRNA-Mediated Regulation of Signaling Pathways in the GC-2 Cell Line.

Authors:  Yong Liu; Wen-Bin Liu; Kai-Jun Liu; Lin Ao; Jia Cao; Julia Li Zhong; Jin-Yi Liu
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

Review 5.  Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies.

Authors:  Jacquelyn W Zimmerman; Hugo Jimenez; Michael J Pennison; Ivan Brezovich; Desiree Morgan; Albert Mudry; Frederico P Costa; Alexandre Barbault; Boris Pasche
Journal:  Chin J Cancer       Date:  2013-11

6.  Distinct epidermal keratinocytes respond to extremely low-frequency electromagnetic fields differently.

Authors:  Chao-Ying Huang; Chun-Yu Chuang; Wun-Yi Shu; Cheng-Wei Chang; Chaang-Ray Chen; Tai-Ching Fan; Ian C Hsu
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

7.  Collective responses in electrical activities of neurons under field coupling.

Authors:  Ying Xu; Ya Jia; Jun Ma; Tasawar Hayat; Ahmed Alsaedi
Journal:  Sci Rep       Date:  2018-01-22       Impact factor: 4.379

8.  Extremely low-frequency electromagnetic fields affect transcript levels of neuronal differentiation-related genes in embryonic neural stem cells.

Authors:  Qinlong Ma; Ping Deng; Gang Zhu; Chuan Liu; Lei Zhang; Zhou Zhou; Xue Luo; Min Li; Min Zhong; Zhengping Yu; Chunhai Chen; Yanwen Zhang
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.